Randomised controlled trials are needed to confirm these disease-modifying effects
Dosing schedules may vary depending on patient goals, metabolic health, and physician guidance
This lower concentration provides more precise dose control, which is valuable during the initial escalation phase
8 Therefore, given the increasing burden of lean MASLD in some populations and the benefits of GLP-1RA in weight management, more clinical attention is warranted
By slowing gastric emptying, they create a feeling of fullness and reduce hunger sensations, helping patients consume fewer calories and experience gradual, sustainable weight loss
We found that supplementation with L-GSH for three months was able to reduce the levels of MDA in all blood components, including plasma ( Figure 4C ), PBMCs ( Figure 4D ), and RBCs ( Figure 4E )